The global cancer vaccines market size was valued at USD 4.5 million in 2022 and is poised to grow at a significant CAGR of 14.1% during the forecast period 2024-30. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore,...

An increase in the accompanying animal population, the growing incidence of zoonotic diseases, and various government initiatives for animal safety & sanity are the main driving factors for the growth of the veterinary vaccines market over the forecast period.   Description Global Veterinary Vaccines Market: by Type (Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion...

Recombinant Vaccines Market Information: By Product (Subunit Recombinant and Attenuated Recombinant Vaccines), by Disease (Cancer, Pneumococcal Disease, Hepatitis B, and DPT), and End-Users (Pediatrics, Adults, and Veterinary) – Global Forecast Till 2027 Market Highlights The recombinant vaccines market is expected to exhibit a CAGR of 6.8% during the forecast period. Vaccines that are...

Recombinant Vaccines Market Information: By Product (Subunit Recombinant and Attenuated Recombinant Vaccines), by Disease (Cancer, Pneumococcal Disease, Hepatitis B, and DPT), and End-Users (Pediatrics, Adults, and Veterinary) – Global Forecast Till 2027 Market Highlights The recombinant vaccines market is expected to exhibit a CAGR of 6.8% during the forecast period. Vaccines that are...

Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market Vaccines Market Size – USD 42 Billion in 2020, Market Growth – 7.3% Market Trends – Expanding pharmaceutical industry and drive to vaccinate all The global Vaccines Market size is expected to reach USD 73.78 billion by 2028,...

Kings Research™ presents this information in its report titled, “Vaccine Market Size, Share & Industry Analysis, By Technology (Live Attenuated Vaccines, Conjugate Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), Disease Indication (Pneumococcal Disease, Influenza, Human Papillomavirus, Meningococcal Disease, Rotavirus, Varicella,...

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2021-2030”. The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and trends related to this evolving segment of...